SCHEMBL2201061

SCHEMBL2201061

O=C(NC1CCOCC1)c1ccc2cccnc2c1O

nearest known ligand 0.55

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 18/20 0.55
ALDH1A1 P00352 1/20 0.53
PDE4B Q07343 1/20 0.49
PDE4D Q08499 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685902 0.88 EGLN1 (0.57) EGLN1ALDH1A1
SCHEMBL7692327 0.88 EGLN1 (0.57) EGLN1ALDH1A1
SCHEMBL16735672 0.87 PDE4B (0.44) EGLN1ALDH1A1PDE4BPDE4D
SCHEMBL7956990 0.86 EGLN1 (0.56) EGLN1ALDH1A1
SCHEMBL7956987 0.86 EGLN1 (0.56) EGLN1ALDH1A1
SCHEMBL7691769 0.85 EGLN1 (0.56) EGLN1ALDH1A1
SCHEMBL7691046 0.82 EGLN1 (0.53) EGLN1ALDH1A1
SCHEMBL8310763 0.81 EGLN1 (0.51) EGLN1ALDH1A1
SCHEMBL8310762 0.81 EGLN1 (0.51) EGLN1ALDH1A1
SCHEMBL2204759 0.80 ALDH1A1 (0.53) EGLN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US claimed
US-8729076-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA (LU) 2014-05-20 US claimed
EP-2519504-B1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM SA (LU) 2014-03-19 EP claimed
EP-2519503-B1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2013-10-23 EP claimed
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM SA (LU) 2012-12-27 US claimed
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES POLICHEM SA (LU) 2012-12-13 US claimed
EP-2519503-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2012-11-07 EP claimed
EP-2345641-A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM S.A. (LU) 2011-07-20 EP claimed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP claimed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO claimed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8969380-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM SA (LU) 2015-03-03 US disclosed
US-8729076-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA (LU) 2014-05-20 US disclosed
US-8729076-B2 Secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM SA (LU) 2014-05-20 US disclosed
EP-2345642-A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents POLICHEM S.A. (LU) 2011-07-20 EP disclosed
EP-2345641-A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives POLICHEM S.A. (LU) 2011-07-20 EP disclosed
WO-2011080266-A1 NEW SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES. POLICHEM S.A. (LU) 2011-07-07 WO disclosed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO disclosed
WO-2011080265-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS POLICHEM S.A. (LU) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329797-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES FOR USE AS ANTIFUNGAL AGENTS ERG28, TUBA8, CYP51A1 EGLN1 1246/4885ALDH1A1 1232/4885PDE4B 2042/4885
US-20120316167-A1 SECONDARY 8-HYDROXYQUINOLINE-7-CARBOXAMIDE DERIVATIVES TUBA8, CYP51A1, ERG28 EGLN1 946/4885ALDH1A1 1383/4885PDE4B 2553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.